Cancer Screening Test Receipt - United States, 2018

MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):29-35. doi: 10.15585/mmwr.mm7002a1.

Abstract

Screening for breast cancer, cervical cancer, and colorectal cancer (CRC) reduces mortality from these cancers.* However, screening test receipt has been below national targets with disparities observed in certain populations (1,2). National Health Interview Survey (NHIS) data from 2018 were analyzed to estimate percentages of adults up to date with U.S. Preventive Services Task Force (USPSTF) screening recommendations. Screening test receipt remained below national Healthy People 2020 (HP2020) targets, although CRC test receipt neared the target. Disparities were evident, with particularly low test receipt among persons who were uninsured or did not have usual sources of care. Continued monitoring helps assess progress toward targets and could inform efforts to promote screening and reduce barriers for underserved populations.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / diagnosis
  • Colorectal Neoplasms / diagnosis
  • Early Detection of Cancer / statistics & numerical data*
  • Female
  • Health Care Surveys
  • Healthcare Disparities
  • Healthy People Programs
  • Humans
  • Male
  • Middle Aged
  • United States
  • Uterine Cervical Neoplasms / diagnosis
  • Young Adult